Skip to main content
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
letter
. 1987 Oct 1;137(7):587-8, 590-1.

Beta-blocker therapy and the risk of anaphylaxis.

J H Toogood
PMCID: PMC1267261  PMID: 2888525

Full text

PDF
587

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Assem E. S., Schild H. O. Antagonism by beta-adrenoceptor blocking agents of the antianaphylactic effect of isoprenaline. Br J Pharmacol. 1971 Aug;42(4):620–630. doi: 10.1111/j.1476-5381.1971.tb07146.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Butchers P. R., Skidmore I. F., Vardey C. J., Wheeldon A. Characterization of the receptor mediating the antianaphylactic effects of beta-adrenoceptor agonists in human lung tissue in vitro. Br J Pharmacol. 1980;71(2):663–667. doi: 10.1111/j.1476-5381.1980.tb10987.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Howard J. C., Cochrane P., Conway M. Practolol and isoprenaline in status asthmaticus. Lancet. 1972 Jul 1;2(7766):47–48. doi: 10.1016/s0140-6736(72)91309-8. [DOI] [PubMed] [Google Scholar]
  4. Wallin J. D. Beta-adrenergic blockers in the hypertensive asthmatic patient? Chest. 1985 Dec;88(6):801–802. doi: 10.1378/chest.88.6.801. [DOI] [PubMed] [Google Scholar]
  5. Wilcox P. G., Ahmad D., Darke A. C., Parsons J., Carruthers S. G. Respiratory and cardiac effects of metoprolol and bevantolol in patients with asthma. Clin Pharmacol Ther. 1986 Jan;39(1):29–34. doi: 10.1038/clpt.1986.5. [DOI] [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES